KK
PTCT icon

Kotler Kevin’s PTC Therapeutics PTCT Stock Holding History

Kotler Kevin’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$380K Buy
+5,000
New +$363K 0.09% 30

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Kotler Kevin's PTCT Position: Q4 2025 in Review

Kotler Kevin opened a new position in PTC Therapeutics (PTCT) in Q4 2025: 5,000 shares worth $380K. The stake represents 0.09% of the portfolio and ranks #30 among its holdings.

353 funds tracked by Wall St. Rank hold PTCT as of Q4 2025.

  • Kotler Kevin held 5,000 shares of PTC Therapeutics worth $380K as of Q4 2025.
  • PTC Therapeutics was a new Kotler Kevin position in Q4 2025.
  • PTC Therapeutics made up 0.09% of Kotler Kevin's portfolio in Q4 2025, its #30 holding.
  • 353 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2025.

Based on Kotler Kevin's 13F filing for Q4 2025, filed 17 Feb 2026.